An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.

The Canadian journal of urology

Volumn 11, Issue 4, 2004, Pages 2327-2340

  McDonald, Heather ^a   Hux, Margaret ^a   Brisson, Marc ^a   Bernard, Lisa ^a   Nickel, J Curtis ^a  

^a i3 Global   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; ENZYME INHIBITOR; FINASTERIDE;

ARTICLE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DRUG COMBINATION; ECONOMICS; HUMAN; MALE; MIDDLE AGED; PROSTATE HYPERTROPHY; STATISTICAL MODEL;

ADRENERGIC ALPHA-ANTAGONISTS; COST-BENEFIT ANALYSIS; DOXAZOSIN; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; PROSTATIC HYPERPLASIA;

EID: 16644388554     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)